Colorectal Cancer - Molecular Basis To Targeted Therapeutics

Grant number: 487922 | Funding period: 2009 - 2013

Completed

Abstract

Cancer of the colon and rectum is the most common form of cancer in Australia. Over 12,000 people are diagnosed each year with colorectal cancer (CRC) and more than one third of people will die of their disease. CRC is caused by mistakes in production of colon cells. Our research aims to discover new ways to detect CRC, develop smart drugs and nanoparticle delivery systems for destroying all types of CRC cells. We will then test our new anti-cancer drugs in clinical trials with CRC patients.

Related publications (20)

Researchers